# Effectiveness of Doxycycline for Treating Pleural Effusions Related to Cancer in an Outpatient Population

> **NCT01411202** · PHASE2 · UNKNOWN · sponsor: **Ottawa Hospital Research Institute** · enrollment: 40 (estimated)

## Conditions studied

- Malignant Pleural Effusion

## Interventions

- **DRUG:** Doxycycline
- **OTHER:** normal saline

## Key facts

- **NCT ID:** NCT01411202
- **Lead sponsor:** Ottawa Hospital Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-06
- **Primary completion:** 2021-12-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2020-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01411202

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01411202, "Effectiveness of Doxycycline for Treating Pleural Effusions Related to Cancer in an Outpatient Population". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01411202. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
